Aim To investigate influence of therapy with new generation antiepileptic drugs (AEDs) in fastening of posttraumatic epilepsy (PTE) remission comparing to therapy with standard AEDs, as well as the time to remission in the presence of psychiatric comorbidities. Methods The study was conducted during the 1988-2008 period and included 113 patients (47 females and 67 males) with PTE and 113 patients (93 females and 20 males) suffering from complex partial seizures (CPS) of temporal lobe origin. In both patient groups, epileptic seizure phenotype, brain magnetic resonance imaging (1.5 T and 3.0 T) and electroencephalogram were analyzed within 24 hours of epileptic seizure and after 5 years of treatment. Psychological testing was administered prior to therapy initiation. Results The patients treated with standard AEDs achieved remission in 82 (73%) cases as compared with 87 (77%) patients administered with a new generation AEDs; in the latter group, remission was achieved faster (1.85 vs. 1.6 months). In both patient groups, psychiatric comorbidity prolonged time to remission by 3.4 months. Conclusion Therapy with new generation AEDs enables achieving faster and complete remission in PTE patients.
Raymont V, Salazar A, Lipsky R, Goldman D, Tasick G, Grafman P, et al. Correlates of posttraumatic epilepsy 35 years following combat brain injury. Neurology. 2010. p. 224–9.
2.
Mazini L, Cossa M, Angelino F, Campini E, Pastore R, Monaco I, et al. Posttraumatic epilepsy: neuroradiologic and neuropsychological assessment of long-term outcome. Epilepsia. 2003. p. 569–74.
3.
Frey C. Epidemiology of posttraumatic epilepsy: a critical review. Epilepsia. 2003. p. 11–7.
4.
Garga N, Lowenstein H. Posttraumatic epilepsy: a major problem in desperate need of major advances. Epilepsy Curr. 2006. p. 1–5.
5.
Gallagher D. Post-traumatic epilepsy: an overview. Einstein Quart J Biol Med. 2002. p. 5–9.
6.
Mori A, Yokoi I, Noda Y, Willmore J. Natural antioxidants may prevent posttraumatic epilepsy: a proposal based on experimental animal studies. Acta Med Okayama. 2004. p. 111–8.
7.
Beghi E. Overview of studies to prevent posttraumatic epilepsy. Epilepsia. 2003. p. 21–6.
8.
Inaba K, Menaker J, Branco C, Gooch J, Okoye T, Herrold J. A prospective multicenter comparison of levetiracetam versus phenytoin for early posttraumatic seizure prophylaxis. Trauma Acute Care Surg. 2010. p. 766–73.
9.
Kellett W, Smith F, Stockton A, Chadwick W. Topiramate in clinical practice: first years postlicensing experience in a specialist epilepsy clinic. J Neurol Neurosurg Psychiatry. 1999. p. 759–63.
10.
Jones E, Puccio A, Harshman H, Falcione B, Benedict N, Jankowitz B. Levetiracetam versus phenytoin for seizure prophylaxis in severe traumatic brain injury. Neurosurg Focus. 2008. p. 1–5.
11.
French A, Kanner M, Bautista J, Abou-Khalil B, Browne T, Harden L, et al. Efficacy and tolerability of the new antiepileptic drugs. I: Treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the. Neurology. American Academy of Neurology and the American Epilepsy Society; 2004. p. 1252–60.
12.
Pohlmann-Eden B, Bruckmeir J. Predictors and dynamics of posttraumatic epilepsy. Acta Neurol Scand. 1997. p. 257–62.
13.
generation AED achieved remission considerably earlier than those administered with a conventional AED, with the time to remission being prolonged by the presence of psychiatric comorbidities. The application of new antiepileptic drugs, especially in presence of psychiatric comorbidity is recommended. FUNDING No specific funding was received for this study.
14.
Tomkins O, Feintuch A, Benifla M, Cohen A, Friedman A, Shelef I. Blood-brain barrier breakdown following traumatic brain injury: a possible role in posttraumatic epilepsy. Cardiovasc Psychiatry Neurol. 2011. p. 756923.
15.
Statler D, Scheerlinck P, Pouliot W, Hamilton M, White S, Dudek E. A potential model of pediatric post-traumatic epilepsy. Epilepsy Res. 2009. p. 221–3.
16.
Diaz-Arrastia R, Agostini A, Madden J, Ness V, C. Posttraumatic epilepsy: the endophenotypes of a human model of epileptogenesis. Epilepsia. 2009. p. 14–20.
17.
Kharatishvili I, Pitkanen A. Posttraumatic epilepsy. Curr Opin Neurol. 2010. p. 183–8.
18.
Prince A, Parada I, Graber K;, Noebels L, Avoli M, Rogawski M, et al. Traumatic brain injury and posttraumatic epilepsy. National Center for Biotechnology Information; 2012.
19.
Hakimian S, Kershenovich A, Miller W, Ojemann J, Hebb O, Ambrosio D, et al. Long-term outcome of extratemporal resection in posttraumatic epilepsy. Neurosurg Focus. 2012. p. 1–9.
20.
Willmore L. Posttraumatic epilepsy: what’s contusion got to do with it? Epilepsy Curr. 2012. p. 87–91.
21.
Storti F, Formaggio E, Franchini E, Bongiovanni G, Cerini R, Fiaschi A. A multimodal imaging approach to the evaluation of post-traumatic epilepsy. Magn Reson Mater Phys. 2012. p. 345–60.
22.
Ferguson L, Smith M, Wannmaker B, Thurman J, Pickelsimer E, Selassie W. A population-based study of risk of epilepsy after hospitalization for traumatic brain injury. Epilepsia. 2010. p. 891–8.
23.
Kapidžić A, Vidović M, Sinanović O. Localisation of war craniocerebral injury as risk factor for posttraumatic epilepsy. Med Arh. 2011. p. 343–4.
24.
Timofeev I, Bazhenov M, Avramescu S, Nita A. Post-traumatic epilepsy: the roles of synaptic plasticity. Neuroscientist. 2010. p. 19–27.
25.
Lowenstein H. Epilepsy after head injury: an overview. Epilepsia. 2009. p. 4–9.
26.
Šepić-Grahovac D, Grahovac T, Ružić-Baršić A, Ružić K, Dadić-Hero E. Lamotrigine treatment of a patient affected by epilepsy and anxiety disorder. Psychiat Danub. 2011. p. 111–3.
27.
Gupta Y, Gupta M. Post traumatic epilepsy: a review of scientific evidence. Indian J Physiol Pharmacol. 2006. p. 7–16.
28.
Klein P, Herr D, Pearl P, Natale J, Levine Z, Nogay C. Results of phase 2 safety and feasibility study of treatment with levetiracetam for prevention of posttraumatic seizures. Arch Neurol. 2012. p. 1290–5.
29.
Marson G, Al-Kharusi M, Alwaidh M, Appleton R, Baker A, Chadwick W. The SANAD study of effectiveness of carbamazepine, gabapentin, lamo-trigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet. 2007. p. 1000–15.
30.
Hajnšek S. Epilepsije: klasifikacija i klinička slika. Neurol Croat. 2010. p. 5–21.
31.
Mellion S, Bennett K, Ellsworth G, Moore K, Riva-Cambrin J, Metzger R. High-dose barbiturates for refractory intracranial hypertension in children with severe traumatic brain injury. Pediatr Crit Care Med. 2013. p. 239–47.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
